Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges

Abstract

The recent coronavirus disease-2019 (COVID-19) outbreak has increased at an alarming rate, representing a substantial cause of mortality worldwide. Respiratory injuries are major COVID-19 related complications, leading to poor lung circulation, tissue scarring, and airway obstruction. Despite an in-depth investigation of respiratory injury’s molecular pathogenesis, effective treatments have yet to be developed. Moreover, early detection of viral infection is required to halt the disease-related long-term complications, including respiratory injuries. The currently employed detection technique (quantitative real-time polymerase chain reaction or qRT-PCR) failed to meet this need at some point because it is costly, time-consuming, and requires higher expertise and technical skills. Polymer-based nanobiosensing techniques can be employed to overcome these limitations. Polymeric nanomaterials have the potential for clinical applications due to their versatile features like low cytotoxicity, biodegradability, bioavailability, biocompatibility, and specific delivery at the targeted site of action. In recent years, innovative polymeric nanomedicine approaches have been developed to deliver therapeutic agents and support tissue growth for the inflamed organs, including the lung. This review highlights the most recent advances of polymer-based nanomedicine approaches in infectious disease diagnosis and treatments. This paper also focuses on the potential of novel nanomedicine techniques that may prove to be therapeutically efficient in fighting against COVID-19 related respiratory injuries.

Polyester Polymeric Nanoparticles as Platforms in the Development of Novel Nanomedicines for Cancer Treatment

“…Allow to design specifically targeted therapies Possibility of designing smart nanosystems capable of responding to external stimuli Nanomedicine can be divided into the following three main areas depending on its application: nanodiagnosis, regenerative medicine, and nanotherapy [12]. The main aim of nanodiagnosis is the early detection of diseases by the use of nanomaterials [13][14][15]. The in vivo diagnosis consists of the administration of different nanodevices for the quantification of several parameters, compounds or metabolites in the organism, while in vitro diagnosis achieves disease detection through samples obtained from patients.…”

Advances and Perspectives in the Use of Carbon Nanotubes in Vaccine Development

“…51 Another approach exploiting nanotechnology to address COVID-19 is the use of polymeric micelles. 52 Single-chain polymers conjugated to specific ligands, which help to engulf or coat the virus, result in neutralization and destabilization of the viral genome. This approach/strategy used coronavirus surface ligands to develop a nanotechnology/nanovaccine called a NanoViricide ® .…”

Polymeric Materials as Potential Inhibitors Against SARS-CoV-2

“…PLGA is a well-established, less toxic biodegradable synthetic copolymer used in FDA-approved pharmaceutical products and medical devices. NPs developed by polymeric materials such as PLGA, PLA, poly(ethylene glycol)-poly(e-caprolactone) (PEG-PCL), and PLA-PEG have been used as nanocarriers drug delivery systems for the antiviral disease treatment [ 142 ]. PLGA NPs have been shown preclinical efficacy in antigen vaccines technology like HBs Ag, Malaria antigens, Bacillus anthracis spores to generate extended cellular and humoral immune response as suitable candidates for encapsulating the antigens within the nanocarrier to provide extended and controlled biological release [ 143 ].…”